“…Notably, the HCMV-encoded protein kinase pUL97 shares important structural and functional features with CDKs, such as structural similarities in the N-and C-terminal lobe of the kinase domain, interaction with cyclins, phosphorylation of identical substrates, and functional complementation in heterologous systems (Chou et al, 2006;Romaker et al, 2006;Chou, 2008;Hume et al, 2008;Hamirally et al, 2009;Kamil et al, 2009;Thomas et al, 2009;Kuny et al, 2010;Graf et al, 2013;Iwahori et al, 2015;Oberstein et al, 2015;Steingruber et al, 2015). A combined regulatory impact of CDK and pUL97 activity on the viral mRNA export factor pUL69 was demonstrated Thomas et al, 2009;Feichtinger et al, 2011;Oberstein et al, 2015) and, very recently, additional posttranslational modification by methylation proved to be similarly important (Thomas et al, 2015). A pronounced kinase inhibitor-induced formation of nuclear speckled aggregation of pUL69 was originally demonstrated by Sanchez & Spector (2006).…”